Silverfin false false 31/05/2024 01/06/2023 31/05/2024 Dr Hans-Juergen Hoppe 05/05/2020 26 February 2025 The principal activity of the Company is the research of molecular diagnostics , biopolymers technology development and provision of support in commercialisation projects for biopharma and biotech start-ups. 12587645 2024-05-31 12587645 bus:Director1 2024-05-31 12587645 2023-05-31 12587645 core:CurrentFinancialInstruments 2024-05-31 12587645 core:CurrentFinancialInstruments 2023-05-31 12587645 core:ShareCapital 2024-05-31 12587645 core:ShareCapital 2023-05-31 12587645 core:RetainedEarningsAccumulatedLosses 2024-05-31 12587645 core:RetainedEarningsAccumulatedLosses 2023-05-31 12587645 core:OtherResidualIntangibleAssets 2023-05-31 12587645 core:OtherResidualIntangibleAssets 2024-05-31 12587645 core:PlantMachinery 2023-05-31 12587645 core:Vehicles 2023-05-31 12587645 core:FurnitureFittings 2023-05-31 12587645 core:OfficeEquipment 2023-05-31 12587645 core:ComputerEquipment 2023-05-31 12587645 core:PlantMachinery 2024-05-31 12587645 core:Vehicles 2024-05-31 12587645 core:FurnitureFittings 2024-05-31 12587645 core:OfficeEquipment 2024-05-31 12587645 core:ComputerEquipment 2024-05-31 12587645 core:CostValuation 2023-05-31 12587645 core:AdditionsToInvestments 2024-05-31 12587645 core:CostValuation 2024-05-31 12587645 2022-05-31 12587645 bus:OrdinaryShareClass1 2024-05-31 12587645 2023-06-01 2024-05-31 12587645 bus:FilletedAccounts 2023-06-01 2024-05-31 12587645 bus:SmallEntities 2023-06-01 2024-05-31 12587645 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 12587645 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12587645 bus:Director1 2023-06-01 2024-05-31 12587645 core:OtherResidualIntangibleAssets core:TopRangeValue 2023-06-01 2024-05-31 12587645 core:PatentsTrademarksLicencesConcessionsSimilar 2023-06-01 2024-05-31 12587645 core:PlantMachinery 2023-06-01 2024-05-31 12587645 core:Vehicles 2023-06-01 2024-05-31 12587645 core:FurnitureFittings 2023-06-01 2024-05-31 12587645 core:OfficeEquipment 2023-06-01 2024-05-31 12587645 core:ComputerEquipment 2023-06-01 2024-05-31 12587645 2022-06-01 2023-05-31 12587645 core:OtherResidualIntangibleAssets 2023-06-01 2024-05-31 12587645 bus:OrdinaryShareClass1 2023-06-01 2024-05-31 12587645 bus:OrdinaryShareClass1 2022-06-01 2023-05-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12587645 (England and Wales)

DAINOMICS LIMITED

Unaudited Financial Statements
For the financial year ended 31 May 2024
Pages for filing with the registrar

DAINOMICS LIMITED

Unaudited Financial Statements

For the financial year ended 31 May 2024

Contents

DAINOMICS LIMITED

COMPANY INFORMATION

For the financial year ended 31 May 2024
DAINOMICS LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 May 2024
DIRECTOR Dr Hans-Juergen Hoppe
REGISTERED OFFICE 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ
United Kingdom
COMPANY NUMBER 12587645 (England and Wales)
ACCOUNTANT Peters Elworthy & Moore
Salisbury House
Station Road
Cambridge
CB1 2LA
DAINOMICS LIMITED

BALANCE SHEET

As at 31 May 2024
DAINOMICS LIMITED

BALANCE SHEET (continued)

As at 31 May 2024
Note 2024 2023
£ £
Fixed assets
Intangible assets 3 5,846 0
Tangible assets 4 50,634 55,383
Investments 5 497 0
56,977 55,383
Current assets
Debtors 6 2,627 21,202
Cash at bank and in hand 2,285 3,476
4,912 24,678
Creditors: amounts falling due within one year 7 ( 65,457) ( 18,382)
Net current (liabilities)/assets (60,545) 6,296
Total assets less current liabilities (3,568) 61,679
Provision for liabilities 8 0 ( 5,035)
Net (liabilities)/assets ( 3,568) 56,644
Capital and reserves
Called-up share capital 9 10 10
Profit and loss account ( 3,578 ) 56,634
Total shareholder's (deficit)/funds ( 3,568) 56,644

For the financial year ending 31 May 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Dainomics Limited (registered number: 12587645) were approved and authorised for issue by the Director on 26 February 2025. They were signed on its behalf by:

Dr Hans-Juergen Hoppe
Director
DAINOMICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2024
DAINOMICS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dainomics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.

The principal trading address is 66 High Street, Bassingbourn, Royston, SG8 5LF.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The Company had net liabilities at the balance sheet date. The financial statements have been prepared on the going concern basis which assumes that the Company will continue as a going concern for the foreseeable future. The trading losses reported to date are consistent with the company's business plan as it progresses its research and development activities.

Given the development progress achieved, the director has a reasonable expectation that the Company will be able to meet its liabilities as they fall due for the foreseeable future and therefore continues to adopt the going concern basis.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover in respect of contracts is recognised as work is carried out by reference to the stage of completion of the contract at the balance sheet date, and when this can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Trademarks, patents and licences

Patents and trademarks , along with associated costs of registering these, are included at cost and amortised in equal annual instalments over a period of 10 years which is their estimated useful economic life. Provision is made for any impairment.

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery 20 % reducing balance
Vehicles 20 % reducing balance
Fixtures and fittings 20 % reducing balance
Office equipment 20 % reducing balance
Computer equipment 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Rentals paid under operating leases are charged to the profit or loss on a straight-line basis over the lease term.

Trade and other debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Trade and other creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Research and development

Research and development expenditure is recognised in the Profit and Loss Account in the period in which the expenditure is incurred.

Investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 01 June 2023 0 0
Additions 5,895 5,895
At 31 May 2024 5,846 5,846
Accumulated amortisation
At 01 June 2023 0 0
Charge for the financial year 49 49
At 31 May 2024 0 0
Net book value
At 31 May 2024 5,846 5,846
At 31 May 2023 0 0

4. Tangible assets

Plant and machinery Vehicles Fixtures and fittings Office equipment Computer equipment Total
£ £ £ £ £ £
Cost
At 01 June 2023 53,721 2,756 4,346 4,016 14,034 78,873
Additions 4,172 0 1,079 184 2,140 7,575
At 31 May 2024 57,893 2,756 5,425 4,200 16,174 86,448
Accumulated depreciation
At 01 June 2023 15,375 138 1,769 388 5,820 23,490
Charge for the financial year 7,982 524 660 735 2,423 12,324
At 31 May 2024 23,357 662 2,429 1,123 8,243 35,814
Net book value
At 31 May 2024 34,536 2,094 2,996 3,077 7,931 50,634
At 31 May 2023 38,346 2,618 2,577 3,628 8,214 55,383

5. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 June 2023 0 0
Additions 497 497
At 31 May 2024 497 497
Carrying value at 31 May 2024 497 497
Carrying value at 31 May 2023 0 0

6. Debtors

2024 2023
£ £
Corporation tax 0 993
Other debtors 2,627 20,209
2,627 21,202

7. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 441 448
Other creditors 65,016 17,934
65,457 18,382

8. Deferred tax

2024 2023
£ £
At the beginning of financial year ( 5,035) 0
Credited/(charged) to the Statement of Income and Retained Earnings 5,035 ( 5,035)
At the end of financial year 0 ( 5,035)

9. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
10 Ordinary shares of £ 1.00 each 10 10

10. Financial commitments

Other financial commitments

2024 2023
£ £
Commitments due within one year 11,209 11,031
Commitments due in more than one year 14,945 26,154
26,154 37,185

11. Dividends

At the time dividends were declared the director was not aware there were insufficient profits available for distribution. The director acknowledges that no further distributions can be made until there are sufficient profits available for that purpose.